Funder: National Institutes of Health (NIH)
Due Dates: October 21, 2025 (Renewal applications only)
Funding Amounts: Up to $400,000 direct costs per year (max 2 years); 1:1 non-Federal cost matching required; total program funding up to $3.5M (across this and companion NOFOs)
Summary: Supports renewal clinical research studies advancing regenerative medicine using adult stem cells, building on prior RMIP-funded clinical trials.
Key Information: Only previous RMIP clinical trial awardees are eligible; strict 1:1 non-Federal cost matching required.